Table 1 Determinants of Markov states in the literature
Markov states defined by: | Bachmann 2006 | Badri et al 2006 | Cleary et al 2006; 2008 | Goldie et al 2006 | Marseille et al 2006 | Vijayaraghavan et al 2007 |
|---|---|---|---|---|---|---|
Baseline CD4 stratum | <200, 200-350, >350 | <50, 50-200 | <50; 50-200; 200-500; >500 | |||
Current CD4 stratum | <200, 200-350 | <200, 200-350, >350 | <50; 50-200; 200-500; >500 | |||
Baseline viral load stratum | >100,000; 30,001-100,000; 10,001-30,000; 3,001-10,000; 501-3,000; 0-500 | |||||
Current viral load stratum | >100,000; 30,001-100,000; 10,001-30,000; 3,001-10,000; 501-3,000; 0-500 | Suppressed; unsuppressed | ||||
Time on ART | 0-3; 3-6; 6-12; 12-24; 24-36; >36 months | |||||
First or second line ARV regimen | Yes | Yes | Yes | Yes | Yes | |
Disease staging or opportunistic infections | Tuberculosis, other opportunistic infection, no opportunistic infection | No-AIDS/ AIDS | Severe bacterial infection; severe fungal infection; severe malaria; tuberculosis; isosporiasis; cerebral toxoplasmosis; nontuberculous mycobacteriosis; other severe opportunistic infection; mild bacterial infection; mild fungal infection; other mild infection | WHO Stages (1, 2, 3, 4) | AIDS | |
Adverse events | Toxicity; no toxicity |